The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Opioid: toward an effective strategy for better use

  • Kim, Yeon-Dong (Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine)
  • Received : 2019.03.12
  • Accepted : 2019.03.12
  • Published : 2019.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; (1): CD006605.
  2. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995; 274: 1870-3. https://doi.org/10.1001/jama.1995.03530230056031
  3. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143-7. https://doi.org/10.1016/S0140-6736(96)90339-6
  4. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6-8. https://doi.org/10.1097/00002508-199703000-00003
  5. Kalso E, Allan L, Dellemijn PL, Faura CC, Ilias WK, Jensen TS, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7: 381-6. https://doi.org/10.1016/S1090-3801(02)00143-X
  6. Hamunen K, Laitinen-Parkkonen P, Paakkari P, Breivik H, Gordh T, Jensen NH, et al. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008; 12: 705-15. https://doi.org/10.1016/j.ejpain.2007.10.012
  7. Siddall PJ, Cousins MJ. Persistent pain as a disease entity: implications for clinical management. Anesth Analg 2004; 99: 510-20. https://doi.org/10.1213/01.ANE.0000133383.17666.3A
  8. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005; 7: R1046-51. https://doi.org/10.1186/ar1782
  9. Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain 2019; 32: 69-78. https://doi.org/10.3344/kjp.2019.32.2.69
  10. Kim ED, Lee JY, Son JS, Byeon GJ, Yeo JS, Kim DW, et al. Guidelines for prescribing opioids for chronic non-cancer pain in Korea. Korean J Pain 2017; 30: 18-33. https://doi.org/10.3344/kjp.2017.30.1.18

Cited by

  1. Medicolegal Consideration to Prevent Medical Malpractice Regarding Opioid Administration: An Analysis of Judicial Opinion in South Korea vol.13, 2019, https://doi.org/10.2147/jpr.s256759
  2. Patients' perception about opioids and addiction in South Korea vol.33, pp.3, 2019, https://doi.org/10.3344/kjp.2020.33.3.234
  3. Agomelatine potentiates anti-nociceptive effects of morphine in a mice model for diabetic neuropathy: involvement of NMDA receptor subtype NR1 within the raphe nucleus and periaqueductal grey vol.42, pp.7, 2019, https://doi.org/10.1080/01616412.2020.1757895
  4. Comparison of Antinociceptive Effect of Octreotide With Morphine in a Rat Model of Acute Inflammatory Pain vol.28, pp.1, 2021, https://doi.org/10.1177/09727531211013004